HC Wainwright Cuts Axsome Therapeutics (NASDAQ:AXSM) Price Target to $180.00
Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its price target reduced by HC Wainwright from $200.00 to $180.00 in a report released on Wednesday,Benzinga reports. HC Wainwright currently has a buy rating on the stock. AXSM has been the topic of several other reports. Bank of America boosted their target price on Axsome Therapeutics from […]
